Using a similar framework, we are working with the community stakeholders to explore the potential for developing treatments targeting two additional proteins with genetic links to PD: Parkin and PTEN-induced putative kinase protein 1 (PINK1). This evidence concerns the gene PRKN and Parkinson disease.